Ubrogepant-d5

SL-10058

Ubrogepant-d₅, >98%

Related CAS No. : [1374248-77-7] of the unlabelled compound

Synonyms : MK-1602-d₅

IUPAC Name : (S)-N-((3S,5S,6R)-6-Methyl-2-oxo-5-(phenyl-d₅)-1-(2,2,2-trifluoroethyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is a deuterium labelled version of Ubrogepant, which is an orally active, selective antagonist of the calcitonin gene-related peptide receptor (CGRP). Ubrogepant demonstrates a strong binding affinity for CGRP receptors in both humans and rhesus monkeys, and inhibits the cAMP response induced by α-CGRP. Ubrogepant is utilized in research related to acute migraine.

References : Moore E. et al.: J. Pharmacol Exp Ther., 119, 261065, 2020; Li C. C. et al.: J. Clin Pharmacol., 58(3), 294-303, 2018.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.